10266
S. Guernelli et al. / Tetrahedron 63 (2007) 10260–10268
phenomenon depends on different kinds of (Z)-hydrazone/b-
CD interactions that can occur at the external shell (still hy-
drophilic) of b-CD or, by contrast, at the internal core (quite
hydrophobic) of b-CD, differently affecting the interaction
of the substrate with the basic catalyst and the formation
of the transition state.
4.3. Synthesis and characterization of the (E)- and (Z)-
isomer of the 5-ethyl and 5-hexyl-1,2,4-oxadiazol-3-yl-
(phenyl)methanone N-hydrazones (1d–e) and of the
relevant triazoles 2d–e
These compounds were prepared according to methods
reported for other Z-hydrazones.15
4. Experimental
4.3.1. (Z)-(5-Ethyl-1,2,4-oxadiazol-3-yl)-(phenyl)metha-
none N-hydrazone (Z-1d). White solid mp 64.2–65.4 ꢃC
(yield 19%). 1H NMR (200 MHz, DMSO) d 1.32 (t,
J¼7.6 Hz, 3H), 3.02 (q, J¼7.6 Hz, 2H), 7.21–7.41 (m,
3H), 7.52–7.61 (m, 2H), 8.45 (br s, 2H). 13C NMR
(200 MHz, DMSO) d 10.5, 19.7, 126.7, 126.9, 127.3,
128.0, 137.3, 162.4, 180.2. ESI–MS m/z¼238.9 [M+Na]+.
Anal. Calcd for C11H12N4O: C, 61.10; H, 5.59; N, 25.91.
Found: C, 61.19; H, 5.64; N, 25.86. HRMS calcd for
C11H12N4O: 216.1011; found 216.1009.
4.1. General synthesis procedure
Compounds (1c, 2c)6a and (1f, 2f)15 were prepared following
known procedures.
4.2. Synthesis and characterization of the (E)- and (Z)-
isomer of the phenylhydrazone of 3-benzoyl-5-hexyl-
1,2,4-oxadiazole (1b) and of the relevant triazole 1d
The (E-1b) and (Z-1b) were synthesized according to known
methods.6a,17 Together with the phenylhydrazones (or the
hydrazones) also a certain amount of the rearranged relevant
triazoles was obtained. In this paper we have examined only
the kinetic behavior of the (Z)-isomers. Concerning the gen-
eral reactivity of the (E)-isomers see Ref. 6c.
4.3.2. (E)-(5-Ethyl-1,2,4-oxadiazol-3-yl)-(phenyl)metha-
none N-hydrazone (E-1d). White solid mp 88.9–90.0 ꢃC
(yield 20%). 1H NMR (200 MHz, DMSO) d 1.28 (t,
J¼7.5 Hz, 3H), 2.89 (q, J¼7.6 Hz, 2H), 7.23–7.59 (m,
7H). 13C NMR (200 MHz, CDCl3) d 10.6, 20.1, 128.6,
129.2, 129.4, 129.5, 135.3, 167.8, 180.3. ESIMS m/z¼
238.9 [M+Na]+. Anal. Calcd for C11H12N4O: C, 61.10; H,
5.59; N, 25.91. Found: C, 61.20; H, 5.68; N, 25.83. HRMS
calcd for C11H12N4O: 216.1011; found 216.1010.
4.2.1. (Z)-Phenylhydrazones of 3-benzoyl-5-hexyl-1,2,4-
oxadiazole (Z-1b). Yellow oil (yield 53%). 1H NMR
(300 MHz, CDCl3) d 0.92 (br t, 3H), 1.32–1.54 (m, 6H),
1.90 (m, 2H), 3.02 (t, J¼7.5 Hz, 2H), 6.94–7.02 (m, 1H),
7.26–7.35 (m, 4H), 7.35–7.48 (m, 3H), 7.86–7.92 (m, 2H),
11.37 (s, 1H). 13C NMR (300 MHz, CDCl3) d 13.9, 22.3,
26.2, 26.3, 28.5, 31.1, 113.8, 121.5, 126.2, 127.8, 127.9,
128.2, 129.1, 136.6, 143.8, 163.2, 178.6. ESIMS
m/z¼347.2 [MꢁH]ꢁ, 371.3 [M+Na]+. Anal. Calcd for
C21H24N4O: C, 72.39; H, 6.94; N, 16.08. Found: C, 72.60;
H, 7.03; N, 16.15. HRMS calcd for C21H24N4O: 348.1950;
found 348.1955.
4.3.3. (Z)-(5-Hexyl-1,2,4-oxadiazol-3-yl)-(phenyl)metha-
none N-hydrazone (Z-1e). White solid mp 57.0–58.5 ꢃC
(yield 39%). H NMR (200 MHz, DMSO) d 0.86 (br t,
1
J¼6.4 Hz, 3H), 1.20–1.48 (m, 6H), 1.76 (m, 2H), 3.00 (t,
J¼7.6 Hz, 2H), 7.22–7.44 (m, 3H), 7.52–7.64 (m, 2H),
8.46 (s, 2H). 13C NMR (200 MHz, DMSO) d 14.0, 22.0,
25.8, 26.0, 28.1, 30.8, 126.6, 127.0, 127.3, 128.0, 137.3,
162.4, 179.4. ESIMS m/z¼295.0 [M+Na]+. Anal. Calcd
for C15H20N4O: C, 66.15; H, 7.41; N, 20.57. Found: C,
66.23; H, 7.34; N, 20.46. HRMS calcd for C15H20N4O:
272.1637; found 272.1642.
4.2.2. (E)-Phenylhydrazone of 3-benzoyl-5-hexyl-1,2,4-
oxadiazole (E-1b). Traces as yellow oil. 1H NMR
(300 MHz, CDCl3) d 0.91 (br t, 3H), 1.28–1.50 (m, 6H),
1.87 (m, 2H), 2.96 (t, J¼7.7 Hz, 2H), 6.90–6.98 (m, 1H),
7.12–7.64 (m, 9H), 8.10 (s, 1H). 13C NMR (75.5 MHz,
CDCl3) d 13.9, 22.3, 26.5, 26.6, 28.7, 31.2, 113.7, 121.5,
128.9, 129.1, 129.6, 129.9, 132.2, 143.0, 168.0, 179.9.
ESIMS m/z¼347.2 [MꢁH]ꢁ, 371.3 [M+Na]+.
4.3.4. (E)-(5-Hexyl-1,2,4-oxadiazol-3-yl)-(phenyl)metha-
none N-hydrazone (E-1e). White solid mp 91.0–93.0 ꢃC
(yield 28%). H NMR (200 MHz, DMSO) d 0.86 (br t,
1
J¼6.6 Hz, 3H), 1.20–1.47 (m, 6H), 1.72 (m, 2H), 2.87 (t,
J¼7.5 Hz, 2H), 7.20–7.57 (m, 7H). 13C NMR (200 MHz,
DMSO) d 14.0, 22.0, 25.8, 26.0, 28.1, 30.8, 129.0, 129.2,
130.9, 131.0, 168.3, 179.0. ESIMS m/z¼295.0 [M+Na]+.
Anal. Calcd for C15H20N4O: C, 66.15; H, 7.41; N, 20.57.
Found: C, 66.21; H, 7.46; N, 20.59. HRMS calcd for
C15H20N4O: 272.1637; found 272.1639.
4.2.3. 4-Heptanoylamino-2,5-diphenyl-1,2,3-triazole
(2b). Thermal rearrangement of 1b gave 2b by heating the
sample (0.2 g) in a preheated oil bath (150 ꢃC) for few min-
utes. By purification on a silica gel column (petroleum ether/
ethyl acetate 85:15) the triazole 2b was obtained in practi-
cally quantitative yields. White solid mp 132.2–132.8 ꢃC.
1H NMR (300 MHz, CDCl3) d 0.89 (broad band, 3H),
1.20–1.44 (broad band, 6H), 1.73 (broad band, 2H), 2.45
(t, J¼7.5 Hz, 2H), 7.30–7.56 (m, 7H), 7.80 (broad band,
2H), 8.04–8.13 (br d, 2H). 13C NMR (75.5 MHz, CDCl3)
d 14.0, 22.4, 25.2, 28.8, 31.4, 36.4, 36.2, 118.4, 126.9,
127.4, 128.6, 129.1, 139.4, 140.1, 142.4, 172.8. ESIMS
m/z¼347.2 [MꢁH]ꢁ, 371.3 [M+Na]+. Anal. Calcd for
C21H24N4O: C, 72.39; H, 6.94; N, 16.08. Found: C, 72.30;
H, 7.10; N, 16.16. HRMS calcd for C21H24N4O: 348.1950;
found 348.1950.
The relevant triazoles (2d–e) were isolated from the reaction
mixture and purified by chromatography; the above com-
pounds could also be obtained from 1d–e by thermally
induced rearrangement (see before).
4.3.5. 5-Phenyl-4-propanoylamino-2H-1,2,3-triazole
(2d). Yellow solid mp 145.8–147.5 ꢃC (yield 14%). 1H
NMR (200 MHz, DMSO) d 1.19 (t, J¼7.6 Hz, 3H), 2.38
(q, J¼7.6 Hz, 2H), 7.35–7.46 (m, 3H), 7.77–7.86 (m, 2H),
9.68 (s, 1H), 12.17 (s, 1H). 13C NMR (200 MHz, CDCl3)
d 10.3, 26.4, 128.1, 128.6, 130.4, 132.2, 145.1, 146.4,